Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Hockeyfan who wrote (647)	3/9/2000 11:21:00 AM
From: Don England	Respond to of 1154

hockey, gene is certainly a choppy one, though maybe not as bad as ngen. got out of all my gene this week at 63. would consider buying back in around 48, the 20 day ema. that seems to be a line that a lot of these bios either hold above or become great buys at or below. (see gztc yesterday.) the valuations are breath-taking, though i doubt if all of them are too high. you simple have to judge the science involved, the pipeline, etc. since i don't have a clue about these things i follow the advice of others i have developed some trust in; there are many such individuals on si. i know, never trust what you read on the threads, except there really are some extremely knowledgable and level-headed folk on these bio-threads. the process is as much in judging their value as in judging the values they place on stocks. i have essentially become a trader in this market. why not? i keep getting great returns, e.g. into aria on advice from si at 18, out at 35, in at 30. it seems to me the only way to play now. find the stocks you covet and get in and out as best you can. it is said that you can't time the market, but i do believe you can time individual stocks enough to make money and remain positioned. all the best, don

To: Hockeyfan who wrote (647)	3/9/2000 12:11:00 PM
From: OldAIMGuy	Read Replies (1) \| Respond to of 1154

Hi H, I agree, any time we see such rapid price appreciation across a sector, it has essentially nothing to do with improvement in the underlying fundamentals of the issues. This is the reason that I adhere to my own strict risk management policies which mandate keeping the risk contained in some fashion. Monday, March 6th may go down as my "high water mark" for the year if enough fat gets trimmed from some of my overweight biotechs. I've been selling in small increments all along the way with GENE and others in this sector of my portfolio. You can see what it looks like at: execpc.com It takes a minute for the graphs to load, so please have patience. Right now I have the Buy Resistance for GENE set very high which will only let me repurchase shares should the price/share fall to something less than $24. By coincidence that is about what the 26 Week Exponential Moving Average is for the stock. There's a pile of momentum players in all of these stocks right now. Should the tide turn against them, they'll head for the exits all at once. No use buying the first shares they will be selling when we can hesitate and buy a basket full later, cheaper. I noted that of the Officers and Directors for GENE, as of last October, I owned more shares than all but three of the nine named. However, since I've been selling quite a bit since then, this is no longer true. A significant part of making money in the market place is learning to keep it once made. You've identified a solid reason for managing risk. Best regards, Tom